Amnon Hoffman

Texas Tech University — United States

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

47h-index7.7kcitations168works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Solubulity and Delivery Systems(32), Advanced Drug Delivery Systems(22), Drug Transport and Resistance Mechanisms(19), Chemical Synthesis and Analysis(16), Peptidase Inhibition and Analysis(14)

Publications167 total

Novel “Solid Lipid Pickering Particles” (SLPPs) for controlled drug delivery
Surfaces and Interfaces·2025Open Access
RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549
Pharmaceuticals·2025Open Access
Effects of a Novel Direct-fed Microbial on Occurrences of Antimicrobial Resistance in Salmonella enterica, Escherichia coli, and Enterococcus spp. Measured Longitudinally From Feedlot Arrival to Harvest in Finishing Beef Steers
Journal of Food Protection·2025Open Access
Real Component Spacers for Two-Stage Exchange Demonstrate Low Bacterial Colonization
Arthroplasty Today·2025Open Access
Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope–Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice
Investigative Ophthalmology & Visual Science·2025· 1 citedOpen Access
The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide
Molecules·2024· 3 citedOpen Access
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis
Pharmaceutics·2024· 1 citedOpen Access
PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs
Oncoscience·2024Open Access
RETRACTED: Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities
Pharmaceuticals·2024· 4 citedOpen Access
Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Antiangiogenic and Melanoma’ Antitumor Activities
Preprints.org·2024· 2 citedOpen Access
Treatment with αvβ3-integrin-specific 29P attenuates pressure-overload induced cardiac remodelling after transverse aortic constriction in mice
Journal of Molecular and Cellular Cardiology Plus·2024· 1 citedOpen Access
Novel phenolate salts of bioactive agents: Cannabidiol phenolate salts
Bioorganic Chemistry·2023· 6 cited
Supplementary Data from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Data from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Supplementary Figure from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Supplementary Figure from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Supplementary Table from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Data from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Supplementary Data from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
Supplementary Table from PH-Binding Motif in PAR<sub>4</sub> Oncogene: From Molecular Mechanism to Drug Design
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Chaim Gilon(12), Oded Ovadia(9), Horst Kessler(8), Michael Friedman(8), Arik Dahan(7), Jayanta Chatterjee(6), Eytan A. Klausner(6), Eran Lavy(6), Abraham J. Domb(6), Irina Cherniakov(5), David Stepensky(5), Pavel Gershkovich(4), Dvora Izgelov(4), Leonid Kagan(4), Raz Jelinek(3), Burkhardt Laufer(3), Sarit Greenberg(3), Elyad Davidson(3), Deborah E. Shalev(3), Éric Biron(2)